New Alzheimer's treatment: Donanemab drug seen as turning point in fight against disease

It's what could be a breakthrough in treating Alzheimer's disease. A new study found that when patients were treated as early as possible with an experimental drug, that it slowed the progression of mental decline in 60 percent of cases. FRANCE 24's Peter O'Brien tells us more.